These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 12479325)
1. Fluoroquinolone-induced retinal degeneration in cats. Wiebe V; Hamilton P J Am Vet Med Assoc; 2002 Dec; 221(11):1568-71. PubMed ID: 12479325 [TBL] [Abstract][Full Text] [Related]
2. Enrofloxacin-associated retinal degeneration in cats. Gelatt KN; van der Woerdt A; Ketring KL; Andrew SE; Brooks DE; Biros DJ; Denis HM; Cutler TJ Vet Ophthalmol; 2001 Jun; 4(2):99-106. PubMed ID: 11422990 [TBL] [Abstract][Full Text] [Related]
3. Information on adverse drug reaction in cats. Davidson M J Am Vet Med Assoc; 2001 Dec; 219(12):1676. PubMed ID: 11767912 [No Abstract] [Full Text] [Related]
4. History and clinical signs. Grahn BH; Storey ES; Cullen CL Can Vet J; 2002 Feb; 43(2):137-8. PubMed ID: 11842601 [No Abstract] [Full Text] [Related]
5. Feline visual changes associated with enrofloxacin. Wilson D Can Vet J; 2002 Mar; 43(3):163. PubMed ID: 11901587 [No Abstract] [Full Text] [Related]
11. Blindness now attributed to enrofloxacin therapy in a previously reported case of a cat with acromegaly treated by cryohypophysectomy. Abrams-Ogg A; Holmberg DL; Quinn RF; Keller C; Wilcock BP; Claffey FP Can Vet J; 2002 Jan; 43(1):53-4. PubMed ID: 11802672 [No Abstract] [Full Text] [Related]
12. Photoreactions with a fluoroquinolone antimicrobial: evening versus morning dosing. Lowe NJ; Fakouhi TD; Stern RS; Bourget T; Roniker B; Swabb EA Clin Pharmacol Ther; 1994 Nov; 56(5):587-91. PubMed ID: 7955823 [TBL] [Abstract][Full Text] [Related]
13. Ocular and systemic manifestations after oral administration of a high dose of enrofloxacin in cats. Ford MM; Dubielzig RR; Giuliano EA; Moore CP; Narfström KL Am J Vet Res; 2007 Feb; 68(2):190-202. PubMed ID: 17269886 [TBL] [Abstract][Full Text] [Related]
14. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats. Boothe DM; Boeckh A; Simpson RB; Dubose K J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841 [TBL] [Abstract][Full Text] [Related]
15. Use of enrofloxacin for treatment of large-form Haemobartonella felis in experimentally infected cats. Dowers KL; Olver C; Radecki SV; Lappin MR J Am Vet Med Assoc; 2002 Jul; 221(2):250-3. PubMed ID: 12118588 [TBL] [Abstract][Full Text] [Related]
16. Intramuscular and oral disposition of enrofloxacin in African grey parrots following single and multiple doses. Flammer K; Aucoin DP; Whitt DA J Vet Pharmacol Ther; 1991 Dec; 14(4):359-66. PubMed ID: 1663561 [TBL] [Abstract][Full Text] [Related]
17. Treatment of opportunistic mycobacterial infections with enrofloxacin in cats. Studdert VP; Hughes KL J Am Vet Med Assoc; 1992 Nov; 201(9):1388-90. PubMed ID: 1331001 [TBL] [Abstract][Full Text] [Related]
18. Phototoxic retinal degeneration and toxicokinetics of sitafloxacin, a quinolone antibacterial agent, in mice. Shimoda K; Okawara S; Kato M Arch Toxicol; 2001 Sep; 75(7):395-9. PubMed ID: 11693179 [TBL] [Abstract][Full Text] [Related]
19. Induction of retinal degeneration in cats by methylnitrosourea and ketamine hydrochloride. Schaller JP; Wyman M; Weisbrode SE; Olsen RG Vet Pathol; 1981 Mar; 18(2):239-47. PubMed ID: 6258283 [TBL] [Abstract][Full Text] [Related]
20. Adverse drug event reports at the United States Food And Drug Administration Center for Veterinary Medicine. Hampshire VA; Doddy FM; Post LO; Koogler TL; Burgess TM; Batten PO; Hudson R; McAdams DR; Brown MA J Am Vet Med Assoc; 2004 Aug; 225(4):533-6. PubMed ID: 15344359 [No Abstract] [Full Text] [Related] [Next] [New Search]